FIELD: medicine.
SUBSTANCE: method involves making use of 0.5-2% aqueous colloid silver solutions. The solutions combine silver and polyvinylpyrrolidon with 7-8% of silver and 92-93% of polyvinylpyrrolidon. The solutions are also usable in preparing water-soluble polymer gels.
EFFECT: enhanced effectiveness of treatment with greater total contact surface acting upon pathogenic flora; high silver introduction rate in pathological focus; no allergic responses observed.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING AND PREVENTING CHRONIC INFLAMMATORY DISEASES OF NASOPHARYNX ASSOCIATED WITH INHALATION EXPOSURE TO BENZENE AND FORMALDEHYDE IN CHILDREN | 2016 |
|
RU2618469C1 |
METHOD OF CONTAMINATED WOUND TREATMENT | 2006 |
|
RU2342120C2 |
METHOD OF TREATING CHRONIC ADENOIDITIS AND TONSILLITIS IN CHILDREN | 2009 |
|
RU2391108C1 |
METHOD FOR CONSERVATIVE TREATMENT OF CHRONIC ADENOIDITIS | 2002 |
|
RU2290932C2 |
AGENT FOR TREATMENT OF CONJUNCTIVA INFLAMMATORY DISEASE, BACTERIAL DAMAGE OF RETINA CAPSULE | 2003 |
|
RU2257210C2 |
METHOD OF INCREASING CLINICAL EFFECTIVENESS OF IMMUNE THERAPY OF CHRONIC ADENOIDITIS USING OZONIZED OIL | 2015 |
|
RU2611344C1 |
METHOD OF TREATING CHILDREN WITH DEGREE 1 AND 2 PHARYNGEAL TONSIL HYPERTROPHY | 2023 |
|
RU2822413C1 |
METHOD FOR NON-SPECIFIC ETIOTROPIC ANTIVIRAL THERAPY IN INFLAMMATORY AND HYPERPLASTIC RHINOPHARYNGEAL DISEASES IN CHILDREN | 2012 |
|
RU2504374C1 |
AGENT "ARGOLIT" FOR TREATMENT OF INFECTED WOUNDS | 2002 |
|
RU2245151C2 |
METHOD OF TREATING OTORHINOLARYNGOLOGICAL INFLAMMATORY DISORDERS | 2014 |
|
RU2572159C1 |
Authors
Dates
2007-10-10—Published
2005-07-19—Filed